INBX 8-K 2026-09-28

Inhibrx Biosciences, Inc. (INBX) 8-K dated 2026-09-28 — accession 0002007919-26-000050. This URL is the filing, not the INBX hub.

Inhibrx Biosciences, Inc. (INBX) is a biotechnology company listed on US.

Inhibrx Biosciences, Inc. filed a 8-K on 2026-09-28. Accession 0002007919-26-000050.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported INBX revenue for 2025-12-31 was $1.3M. Net income was -$140.1M. Revenue was up 550.0% from 2024-12-31 to 2025-12-31. INBX currently screens at market cap $1.28B.

Not investment advice. The INBX SEC hub lists recent forms. The stock page is the research view.